2StrutherS AD.Aldosterone escape during ACE inbibitor therapy in chronic heart failure[J].Eur Heart J,1995,16(54PPLN):103-106.
3Thurmann PA,Kenadi P,Schmidt A et al:Influence of the angiotensin I antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension[J].Circulation,1998,98(19):2037-2042.
4Ambrose J.Pribnow DG,Girand GD et a1.Angiotensin type 1 receptor antagomsm with irbesartan inhibits ventricular hypertrophy and improves diastolic function in remodeling postmyocardial in faretion ventricle[J].J Am Soc Nephrol,1999’10(1):129-136.
5Bertrand ME. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials[ J]. Curr Med Resopin,2004,20(10): 1559-1569.
6Hilgers KF, Dotseh J, Kascher W, et al. Treatment strategies in patients. with chronic renal disease, ACEI inhibitors, angiotensin receptor antagonists, or both[J]. Pediatr Nephro,2004,19(9) :956-961.
7Amenta F, Mignini F, Rabbia F, et al. Protective effect of anti - hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data[J]. Neural Sci,2002,204:147-151.
8Ohta T,Hasebe N,Tsuji S,et al. Unequal effects of renin-angiontensin system inhibitors in acute cardiac dysfunction induced by isoprotereno [ J ]. Physiol Heart circ physiol ,2004 ,287 ( 6 ) : H2914-2921.
9Raiz-Ortega M,Conzalez S,Seron D,et al. ACE inhibition reduce sproteinria,glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis[ J ]. kidney Int, 1995,48:1778.
10Blais C Jr,Rouleau JL,Brown NT,et al. Serum metabolism of brady kinin and des-Arg, 9-bradykinin inpatients with angiotension coverting enzyme inhibitorassociated angioedema [ J ]. Immunopharmacology, 1999,43 (2 - 3 ) :293.
